- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sandu Pharmaceuticals' members have approved the appointment of M/S Swapnil J Dixit & Associates as the company's Secretarial Auditor for five consecutive years. This appointment is effective from the financial year 2025-26 through 2029-30, following the completion of the previous term. This re-appointment of the existing auditor ensures continued adherence to corporate governance standards and regulatory requirements, reinforcing the company's commitment to compliance and transparency for its shareholders.